1
HIGHLIGHTS NATURE REVIEWS | IMMUNOLOGY VOLUME 4 | MAY 2004 | 317 HIGHLIGHT ADVISORS CEZMI AKDIS SWISS INSTITUTE OF ALLERGY AND ASTHMA RESEARCH, SWITZERLAND BRUCE BEUTLER SCRIPPS RESEARCH INSTITUTE, USA PETER CRESSWELL YALE UNIVERSITY, USA JAMES DI SANTO PASTEUR INSTITUTE, FRANCE GARY KORETZKY UNIVERSITY OF PENNSYLVANIA, USA CHARLES MACKAY GARVAN INSTITUTE OF MEDICAL RESEARCH, AUSTRALIA CORNELIS J. M. MELIEF LEIDEN UNIVERSITY MEDICAL CENTRE, THE NETHERLANDS MICHEL NUSSENZWEIG THE ROCKEFELLER UNIVERSITY, USA SARAH ROWLAND-JONES CENTRE FOR TROPICAL MEDICINE, OXFORD, UK ALAN SHER NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASE, USA ANDREAS STRASSER THE WALTER AND ELIZA HALL INSTITUTE, AUSTRALIA MEGAN SYKES HARVARD MEDICAL SCHOOL, USA ERIC VIVIER CENTRE D’IMMUNOLOGIE DE MARSEILLE-LUMINY, FRANCE MATTHIAS VON HERRATH LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY, USA. One way in which HIV can avoid detection by the immune system is to mutate the protein epitopes that are presented by infected cells on MHC class I molecules to cytotoxic T lym- phocytes (CTLs). Philip Goulder and colleagues have now shown for the first time in a natural human infection that HIV can also take an indirect route to CTL escape by mutating residues outside of CTL epitopes that affect antigen processing. This study identified a polymor- phism at amino-acid residue 146 (alanine to proline; A146P) of the HIV-1 protein Gag that is more common in patients expressing the MHC class I molecule HLA-B57. The authors show that the observed variation at Gag residue 146 is the result of selection pressure mediated by HLA-B57. For example, in known examples of wild-type HIV transmission from an HLA-B57 mother to an HLA-B57 + child, the A146P mutation arose subsequent to transmission in the child. In HLA-B57 + individuals infected with HIV-1, the A146P mutation is associated with a 22-fold increase in viral load compared with wild-type virus, resulting in an increased risk of progression to AIDS. CD4 + T cells from an uninfected HLA-B57 + donor that were infected in vitro with a virus construct containing the A146P mutation could not be lysed by CTLs specific for the epitope ISW9, in con- trast to cells infected with wild-type virus constructs. Surprisingly, how- ever, residue 146 does not lie within ISW9 (Gag residues 147–155), but instead is found immediately pre- ceding the amino terminus of this epitope. The authors suggest that the mutation at residue 146 affects the pathway by which proteins become presented on MHC molecules, and therefore indirectly affects CTL recog- nition, because the unmutated epi- tope itself never reaches the surface of the cell. In support of this, the endo- plasmic-reticulum aminopeptidase ERAP1 could not cut amino-terminal- extended ISW9 peptides that con- tained proline, rather than alanine, at residue 146. ERAP1 is involved in anti- gen presentation by trimming peptide epitopes to the correct length to bind MHC class I molecules, so the failure of A146P-containing peptides to be trimmed could result in poor pre- sentation on the surface of HIV- infected cells and therefore poor CTL recognition and killing. This indirect mechanism of CTL escape has been postulated by many researchers on the basis of artificial mutation studies, but this is the first time that it has been shown to occur naturally. The research has impor- tant implications for vaccine design as it indicates that the residues between epitopes are also crucial for an efficient CTL response. Kirsty Minton References and links ORIGINAL RESEARCH PAPER Draenert, R. et al. Immune selection for altered antigen processing leads to cytotoxic T lymphocyte escape in chronic HIV-1 infection. J. Exp. Med. 199, 905–915 (2004) FURTHER READING Phillips, R. E. Immunology taught by Darwin. Nature Immunol. 3, 987–989 (2002) HIV takes the indirect route IMMUNE EVASION

Immune evasion: HIV takes the indirect route

  • Upload
    kirsty

  • View
    215

  • Download
    1

Embed Size (px)

Citation preview

HIGHLIGHTS

NATURE REVIEWS | IMMUNOLOGY VOLUME 4 | MAY 2004 | 317

HIGHLIGHT ADVISORS

CEZMI AKDIS

SWISS INSTITUTE OF ALLERGYAND ASTHMA RESEARCH,SWITZERLAND

BRUCE BEUTLER

SCRIPPS RESEARCH INSTITUTE,USA

PETER CRESSWELL

YALE UNIVERSITY, USA

JAMES DI SANTO

PASTEUR INSTITUTE, FRANCE

GARY KORETZKY

UNIVERSITY OFPENNSYLVANIA, USA

CHARLES MACKAY

GARVAN INSTITUTE OFMEDICAL RESEARCH,AUSTRALIA

CORNELIS J. M. MELIEF

LEIDEN UNIVERSITY MEDICALCENTRE, THE NETHERLANDS

MICHEL NUSSENZWEIG

THE ROCKEFELLER UNIVERSITY,USA

SARAH ROWLAND-JONES

CENTRE FOR TROPICALMEDICINE, OXFORD, UK

ALAN SHER

NATIONAL INSTITUTE OFALLERGY AND INFECTIOUSDISEASE, USA

ANDREAS STRASSER

THE WALTER AND ELIZA HALLINSTITUTE, AUSTRALIA

MEGAN SYKES

HARVARD MEDICAL SCHOOL,USA

ERIC VIVIER

CENTRE D’IMMUNOLOGIE DEMARSEILLE-LUMINY, FRANCE

MATTHIAS VON HERRATH

LA JOLLA INSTITUTE FORALLERGY AND IMMUNOLOGY,USA.

One way in which HIV can avoiddetection by the immune system is tomutate the protein epitopes that arepresented by infected cells on MHCclass I molecules to cytotoxic T lym-phocytes (CTLs). Philip Goulder andcolleagues have now shown for thefirst time in a natural human infectionthat HIV can also take an indirectroute to CTL escape by mutatingresidues outside of CTL epitopes thataffect antigen processing.

This study identified a polymor-phism at amino-acid residue 146(alanine to proline; A146P) of theHIV-1 protein Gag that is morecommon in patients expressing theMHC class I molecule HLA-B57.The authors show that the observedvariation at Gag residue 146 is theresult of selection pressure mediatedby HLA-B57. For example, inknown examples of wild-type HIVtransmission from an HLA-B57–

mother to an HLA-B57+ child, theA146P mutation arose subsequentto transmission in the child.

In HLA-B57+ individuals infectedwith HIV-1, the A146P mutation isassociated with a 22-fold increase inviral load compared with wild-typevirus, resulting in an increased risk ofprogression to AIDS. CD4+ T cellsfrom an uninfected HLA-B57+ donorthat were infected in vitro with a virusconstruct containing the A146Pmutation could not be lysed by CTLsspecific for the epitope ISW9, in con-trast to cells infected with wild-typevirus constructs. Surprisingly, how-ever, residue 146 does not lie within

ISW9 (Gag residues 147–155), butinstead is found immediately pre-ceding the amino terminus of thisepitope. The authors suggest that themutation at residue 146 affects thepathway by which proteins becomepresented on MHC molecules, andtherefore indirectly affects CTL recog-nition, because the unmutated epi-tope itself never reaches the surface ofthe cell.

In support of this, the endo-plasmic-reticulum aminopeptidaseERAP1 could not cut amino-terminal-extended ISW9 peptides that con-tained proline, rather than alanine, atresidue 146. ERAP1 is involved in anti-gen presentation by trimming peptideepitopes to the correct length to bindMHC class I molecules, so the failureof A146P-containing peptides to be

trimmed could result in poor pre-sentation on the surface of HIV-infected cells and therefore poorCTL recognition and killing.

This indirect mechanism of CTLescape has been postulated by manyresearchers on the basis of artificialmutation studies, but this is the firsttime that it has been shown to occurnaturally. The research has impor-tant implications for vaccine designas it indicates that the residuesbetween epitopes are also crucial foran efficient CTL response.

Kirsty MintonReferences and links

ORIGINAL RESEARCH PAPER Draenert, R. et al.Immune selection for altered antigen processingleads to cytotoxic T lymphocyte escape in chronicHIV-1 infection. J. Exp. Med. 199, 905–915 (2004)FURTHER READING Phillips, R. E. Immunologytaught by Darwin. Nature Immunol. 3, 987–989(2002)

HIV takes the indirect route

I M M U N E E VA S I O N